beauty-features
beauty-features

Revlon, Arden See Losses for Quarter

beauty-features/news

Both Revlon Inc. and Elizabeth Arden Inc. posted losses for the first three months of the year as the consumer became more tentative.

Revlon’s first-quarter losses narrowed to $2.5 million, or breakeven on a per-share basis, from red ink of $35.2 million, or 7 cents, a year earlier. Sales for the three months ended March 31 dipped 2.5 percent to $320.4 million.

 

U.S. sales for the company fell 8.3 percent to $177.2 million as international turnover rose 5.8 percent to $143.2 million.

 

David Kennedy, Revlon’s president and chief executive officer, said the plan was to boost sales of new products while controlling costs.

 

“All combined, we expect to generate sustainable, profitable sales growth and positive free cash flow,” said Kennedy.

 

At Arden, losses in its third quarter, which also ended March 31, weighed in at $3.8 million, or 14 cents a share. That compared with earnings of $3.2 million, or 11 cents, a year earlier. Sales for the three months fell 4 percent to $210.6 million.

 

“While we were not expecting any improvement in the retail environment this past quarter in North America, we did not anticipate the extent of the negative retail sales trends,” said E. Scott Beattie, chairman, president and ceo.

 

For complete coverage, see Friday’s issue of WWD.

 

ADD A COMMENT

Sign in using your Facebook or Twitter account, or simply type your comment below as a guest by entering your email and name. Your email address will not be shared.

ArticleFinder

Beauty


Choose By

Clear

How it works

Close

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.


Or

Follow Us

Publications

MostPopular